The tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when ...

Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets, strengthening position in US market.

Zydus Lifesciences Ltd on Wednesday (March 5) said it has received final approval from the United States Food and Drug ...

Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multiple strengths. The ...

Zydus Lifesciences has received USFDA approval to manufacture its generic version of Methenamine Hippurate tablets for ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture ...

Zydus Lifescienceshas received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram (USRLD: Hiprex Tablets, 1 gram).

Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture Methenamine Hippurate Tablets.

hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (FDA) to manufacture ibuprofen and famotidine tablets, 800 mg/26.6 mg. (USRLD: Duexis ...

Dasatinib is the generic version of Sprycel® tablets, a medication widely used for treating Ph+, chronic myeloid leukemia ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram ...

The company launched ANVIMO (Letermovir), a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic stem cell transplant (HSCT) and kidney transplant patients. ANVIMO will ...